This is a service of EIN News a digital news provider
Pharmaceutical Industry Today
Sign up for a free trial
Register Now
Member center Log In
California Pharmaceutical Research & Development News is an EIN News Service for pharmaceuticals professionals. Constantly updated news and information about California Pharmaceuticals.
FORMATS: RSS | EMAIL

Latest California Pharmaceutical Research & Development News

Sort by: relevance (24 hours) relevance date
  • Threshold Pharmaceuticals 3Q loss widens on costs 7 Nov 2009 03:32 GMT
    ... Threshold Pharmaceuticals 3Q loss widens on costs REDWOOD CITY, ... CITY, Calif. -- Threshold Pharmaceuticals Inc., a development-stage biotechnology company, said late Thursday its third-quarter ... Thursday its third-quarter loss widened on higher research, development, and interest expenses. The company lost ...

  • Marriages of convenience: Medical groups join with food companies [BC-COMPANIES-HEALTHIMAGE-ADV08:KC] 7 Nov 2009 02:13 GMT
    ... and the National Institutes of Health on research as early as the 1940s. Now an ... to become less financially reliant on the pharmaceutical industry, he said. Because of Big Pharma's ... objected to the academy's financial ties to drug companies. "Overall, I think the AAFP is a ...

  • Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus 7 Nov 2009 04:30 GMT
    ... has been awarded a Small Business Innovative Research (SBIR) Phase I contract by the U.S. ... Under terms of the agreement, Calbiotech will develop analyte specific reagents (ASRs) for the diagnosis ... animal species that are used by major pharmaceutical companies, universities and research centers. Calbiotech provides ...

  • Environmental challenges drive research in catalysis 7 Nov 2009 09:49 GMT
    ... science press. For her outstanding achievements in developing new catalytic concepts in organic synthesis Professor ... to make new molecules relevant to the pharmaceutical, fine chemical and agrochemical industries”, Sanford says. ... of Heidelberg, BASF SE and the Collaborative Research Center “Molecular Catalysts”, the biennial international congress ...

  • NeurogesX Reports Third Quarter 2009 Results 7 Nov 2009 04:30 GMT
    ... of Qutenza(TM) E.U. Marketing Authorization to Astellas Pharma Europe Ltd. Made significant progress in commercial readiness activities ... (Nasdaq: NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today ... Director, Marketing; and Director, Commercial Operations Market research updates to support launch planning and sales ...

  • Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 7 Nov 2009 04:30 GMT
    ... RDEA), a biotechnology company focused on the development of small-molecule therapeutics for the treatment of ... combination with allopurinol and febuxostat (Uloric®, Takeda Pharmaceutical Company Limited; Adenuric®, Ipsen) and an update ... earned in fiscal 2008 resulted from the research services we provided under our master services ...

  • Computers Reveal Unexpected Drug Side Effects 7 Nov 2009 00:33 GMT
    ... The researchers developed a computational method that compares how similar ... author Bryan Roth, M.D., Ph.D., professor of pharmacology and director of the National Institute of Mental ... Study co-authors from UNC include Vincent Setola, research associate professor; Atheir Abbas, former graduate student; ...

  • Computational Method Points To New Uses, Unexpected Side Effects Of Already Existing Drugs 7 Nov 2009 01:16 GMT
    ... The researchers developed a computational method that compares how similar ... author Bryan Roth, M.D., Ph.D., professor of pharmacology and director of the National Institute of Mental ... Study co-authors from UNC include Vincent Setola, research associate professor; Atheir Abbas, former graduate student; ...

  • Halozyme Study Results Demonstrate Significantly Less Absorption Variability for Insulin Lispro Administered with PH20 E 7 Nov 2009 02:34 GMT
    ... with PH20 across a number of key pharmacokinetic measures, especially during the first two hours ... Doug Muchmore, M.D., vice president, endocrinology clinical development. "For diabetes patients this could mean more ... Liquid . The product candidates in Halozyme's research pipeline target multiple areas of significant unmet ...

  • GlaxoSmithKline and XenoPort Announce Extension of GSK1838262 (XP13512) FDA Review Date to February 9, 2010 7 Nov 2009 01:30 GMT
    ... LONDON & RESEARCH TRIANGLE PARK, N.C. & SANTA CLARA, Calif.--(BUSINESS ... - one of the world's leading research-based pharmaceutical and healthcare companies - is committed to ... XenoPort is a biopharmaceutical company focused on developing a portfolio of internally discovered product candidates ...

  • PROFNET EXPERT ALERTS: Alzheimer's / Holiday Blues / Sustainable Living 7 Nov 2009 01:12 GMT
    ... previously at 1. ED MORGAN, immunologist and research professor at SAN DIEGO STATE UNIVERSITY's BioScience ... implant done." Heil is an expert in developing quality assurance systems to help understand and ... and medical practices, between practices and the pharmacies, and between insurance companies and hospitals. In the ...

  • Hamilton Thorne files second quarter results as part of qualifying transaction requirements 7 Nov 2009 00:13 GMT
    ... systems and instruments for the stem cell research and fertility clinic markets, today reported operational ... total operating expenditures were $1,048,000. Research and development expenses for the quarter were $221,000. Sales ... procedures. Hamilton Thorne's growing customer base includes pharmaceutical companies, biotechnology companies, fertility clinics, university research ...

  • Neurogen Corp. reports $1.9M loss, sells real estate 7 Nov 2009 11:57 GMT
    ... Industrial Road to a commercial real estate developer. The biotech company had a net loss ... August it would be acquired by Ligand Pharmaceuticals Inc., a California company that will not ... company prepares to shut down local operations, research and development expenses as well as general ...

  • Neurogen Corp. reports $1.9M loss, sells real estate [New Haven Register, Conn.] 7 Nov 2009 13:05 GMT
    ... Industrial Road to a commercial real estate developer. The biotech company had a net loss ... August it would be acquired by Ligand Pharmaceuticals Inc., a California company that will not ... company prepares to shut down local operations, research and development expenses as well as general ...

  • Medina International Holdings, Inc. Completes Acquisition of Harbor Guard Boats, Inc. 7 Nov 2009 00:12 GMT
    ... Inc. Mr. EAST MILLSTONE, N.J.--(BUSINESS WIRE)--Life Sciences Research, Inc. (NYSE: LSR) announced today that RiskMetrics ... it has completed its acquisition of Excel PharmaStudies, Inc., the market leader and one of ... acquisition strengthens PPD's full range of drug development services in the country and positions it ...


1 - 15 / 2761      NEXT >>>

Powered by Newsfeed Maker
NOT SATISFIED WITH THIS CALIFORNIA PHARMACEUTICAL RESEARCH & DEVELOPMENT NEWS SECTION? MAKE YOUR OWN WITH THE INBOX ROBOT OR TRY OUR OTHER MEDIA MONITORING SERVICES.
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>>
 
 

Take This Poll

According to the White House, 650,000 jobs were created or saved by $150 billion in stimulus funds. Was it money well spent? (Oct. 30, 2009)



 

BUSINESS PROMOTION SERVICES

EIN Advertising · Place banner ads on EIN News industry specific publications.

EIN Presswire · Upload press releases to the EIN network and have them submitted to leading journalists and decision-makers worldwide.

EIN Global Events · Reach industry-specific readers and promote events, conferences or exhibitions.

EIN Business Directory · Present company or service information on highly-visible, industry and geo-specific news pages.

NEWS SERVICES

News Publications · In-depth geopolitical and industry specific news coverage aggregated from 35,000 online outlets. Updated every 15 minutes.

News Alerts · Receive a free selection of the day's top stories hand picked by EIN News editors.

Newsfeed Maker · Integrate customized newsfeeds in any format covering all industry and geopolitical topics, updated every 15 minutes.

EIN Presswire · Upload press releases to the EIN network and have them submitted journalists and decision-makers worldwide.

Inbox Robot · Customized newsletters delivered by e-mail. Search a news index monitoring thousands of trusted media sources.

COMPANY BACKGROUND

About EIN News · Established in 1995, EIN News began by supplying business professionals and individuals with relevant and interesting news products. It has grown to become the largest digital news provider in Europe.

Member List · See the partial member list and join a community of professionals from private industry, institutions, and governments that rely on EIN as a critical source for research, breaking news and media services.